Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Laryngoscope ; 131(5): 1122-1126, 2021 05.
Artigo em Inglês | MEDLINE | ID: mdl-33135838

RESUMO

OBJECTIVES/HYPOTHESIS: Previous research has shown hearing handicap to be reduced following hearing aid use or cochlear implantation in short-to-medium follow-up periods, yet the impact of interventions for hearing loss on hearing handicap in the long term remains understudied. This article reports hearing handicap at 6 months, 12 months, and 5 years after either hearing aid provision or cochlear implantation. STUDY DESIGN: Observational study. METHODS: A study of 115 participants from the Studying Multiple Outcomes after Aural Rehabilitative Treatment (SMART) study cohort assessed self-reported hearing handicap using the Hearing Handicap Inventory for the Elderly Screening version (HHIE-S) at baseline, 6 months, 12 months, and 5 years. Generalized estimating equations (GEE) were used to estimate the population mean HHIE-S score over time, accounting for the correlated nature of repeated measures data, and multiple imputation with chained equations was performed to impute missing data. RESULTS: Compared to baseline, mean HHIE-S scores after hearing aid provision were significantly reduced at 6 months (mean = -7.96, 95% confidence interval [CI]: -10.40, -5.53), 12 months (mean = -6.58, 95% CI: -9.26, -3.90), and 5 years (mean = -4.58, 95% CI: -7.87, -1.30). After cochlear implantation, mean hearing handicap scores were also significantly lower compared to baseline at 6 months (mean = -8.18, 95% CI: -11.07, -5.30), 12 months (mean = -10.04, 95% CI: -12.92, -7.16), and 5 years (mean = -8.97, 95% CI: -12.92, -7.16). CONCLUSIONS: This study found short-term benefits from hearing aids and cochlear implantation on hearing handicap were maintained over 5 years. Laryngoscope, 131:1122-1126, 2021.


Assuntos
Implante Coclear , Auxiliares de Audição , Perda Auditiva/terapia , Qualidade de Vida , Idoso , Avaliação da Deficiência , Feminino , Seguimentos , Perda Auditiva/complicações , Perda Auditiva/diagnóstico , Perda Auditiva/psicologia , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Autorrelato/estatística & dados numéricos , Índice de Gravidade de Doença , Fatores de Tempo , Resultado do Tratamento
2.
Artigo em Inglês | MEDLINE | ID: mdl-29987146

RESUMO

The nosocomial pathogen Candida albicans forms biofilms on medical devices that persist in the face of antifungals and host defenses. Echinocandins, the most effective antibiofilm drugs, have recently been shown to augment the activity of neutrophils against biofilms through an unknown mechanism. Here, we show that treatment of C. albicans biofilms with subinhibitory concentrations of echinocandins promotes the formation of neutrophil extracellular traps (NETs), structures of DNA, histones, and antimicrobial proteins with antifungal activity.


Assuntos
Antifúngicos/farmacologia , Biofilmes/efeitos dos fármacos , Candida albicans/imunologia , Equinocandinas/farmacologia , Armadilhas Extracelulares/efeitos dos fármacos , Neutrófilos/imunologia , Candida albicans/efeitos dos fármacos , Humanos , Testes de Sensibilidade Microbiana , Neutrófilos/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...